Guizhou Xinbang Pharmaceutical Co Ltd (002390) — Cash Flow-to-Debt Ratio
Guizhou Xinbang Pharmaceutical Co Ltd (002390) has a Cash Flow-to-Debt Ratio of 0.14x as of September 2025, meaning its operating cash flow of CN¥234.19 Million could theoretically repay 0% of its total liabilities (CN¥1.62 Billion) in one year. Explore long-term investment intensity of Guizhou Xinbang Pharmaceutical Co Ltd to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Guizhou Xinbang Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2006–2024)
Historical debt coverage capacity for Guizhou Xinbang Pharmaceutical Co Ltd across 19 annual periods. Also explore balance sheet size of Guizhou Xinbang Pharmaceutical Co Ltd for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Guizhou Xinbang Pharmaceutical Co Ltd (2006–2024)
Year-by-year debt coverage analysis for Guizhou Xinbang Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see 002390 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.32x | CN¥634.97 Million | CN¥2.01 Billion | ▼ -15.9% |
| 2023 | 0.38x | CN¥790.62 Million | CN¥2.10 Billion | ▲ +73.6% |
| 2022 | 0.22x | CN¥590.80 Million | CN¥2.73 Billion | ▲ +32.4% |
| 2021 | 0.16x | CN¥457.97 Million | CN¥2.80 Billion | ▼ -1.0% |
| 2020 | 0.17x | CN¥742.11 Million | CN¥4.49 Billion | ▲ +0.1% |
| 2019 | 0.17x | CN¥886.33 Million | CN¥5.37 Billion | ▲ +529.3% |
| 2018 | -0.04x | CN¥-218.56 Million | CN¥5.69 Billion | ▼ -199.0% |
| 2017 | 0.04x | CN¥201.74 Million | CN¥5.20 Billion | ▲ +184.3% |
| 2016 | -0.05x | CN¥-198.59 Million | CN¥4.31 Billion | ▼ -181.3% |
| 2015 | 0.06x | CN¥217.40 Million | CN¥3.84 Billion | ▲ +178.9% |
| 2014 | -0.07x | CN¥-198.60 Million | CN¥2.77 Billion | ▼ -51.7% |
| 2013 | -0.05x | CN¥-21.34 Million | CN¥450.69 Million | ▲ +59.5% |
| 2012 | -0.12x | CN¥-36.46 Million | CN¥311.99 Million | ▲ +22.6% |
| 2011 | -0.15x | CN¥-39.87 Million | CN¥264.02 Million | ▼ -1101.1% |
| 2010 | 0.02x | CN¥2.50 Million | CN¥165.81 Million | ▼ -92.1% |
| 2009 | 0.19x | CN¥41.75 Million | CN¥217.51 Million | ▲ +81.5% |
| 2008 | 0.11x | CN¥24.86 Million | CN¥235.04 Million | ▼ -29.3% |
| 2007 | 0.15x | CN¥32.49 Million | CN¥216.99 Million | ▲ +379.3% |
| 2006 | 0.03x | CN¥7.35 Million | CN¥235.18 Million | — |